高级检索
    贾慧英. 肺功能指标检测在老年慢性阻塞性肺疾病(COPD)和冠心病中的诊断及鉴别价值研究[J]. 徐州医科大学学报, 2019, 39(12): 889-892.
    引用本文: 贾慧英. 肺功能指标检测在老年慢性阻塞性肺疾病(COPD)和冠心病中的诊断及鉴别价值研究[J]. 徐州医科大学学报, 2019, 39(12): 889-892.
    shu
    The va1ue of pu1monary function test in the diagnosis and differentia1 diagnosis of chronic obstructive pu 1monary disease (COPD) and coronary heart disease in the e1der1y[J]. Journal of Xuzhou Medical University, 2019, 39(12): 889-892.
    Citation: The va1ue of pu1monary function test in the diagnosis and differentia1 diagnosis of chronic obstructive pu 1monary disease (COPD) and coronary heart disease in the e1der1y[J]. Journal of Xuzhou Medical University, 2019, 39(12): 889-892.
    shu

    肺功能指标检测在老年慢性阻塞性肺疾病(COPD)和冠心病中的诊断及鉴别价值研究

    The va1ue of pu1monary function test in the diagnosis and differentia1 diagnosis of chronic obstructive pu 1monary disease (COPD) and coronary heart disease in the e1der1y

      摘要
    • 摘要: 目的：研究肺功能指标检测在老年慢性阻塞性肺疾病(COPD)和冠心病中的诊断及鉴别价值。方法：研究对象选取我院2015年3月到2017年3月收治的CODP和冠心病确诊患者各60例，分别作为COPD组和冠心病组，同期选取60例健康体检者作为对照组。采用Masterscreen PFT肺功能仪，对所有患者和体检组均进行常规肺通气、弥散功能以及肺容量测定，测定肺通气功能、肺弥散功能以及肺容量等指标。分析肺功能指标在COPD和冠心病中的诊断和鉴别价值。结果：COPD组和冠心病组的VC、FVC、FEV1、FEVI/FVC、PEF、DLCO、DLCO/VA、FRC指标水平均明显低于对照组(P<0.01)，COPD组则均明显低于冠心病组(P<0.01)；COPD组和冠心病组的FRC、TLC、RV及RV/TLC等指标水平均明显低于对照组(P<0.01)，COPD组则均明显低于冠心病组(P<0.01)；COPD组和冠心病组的FRC、RV及RV/TLC值明显高于对照组(P<0.01)，COPD组则均明显高于冠心病组(P<0.01)。结论：检测肺功能指标能够有效诊断老年COPD和冠心病发生，同时可有效鉴别老年COPD和冠心病，对早期诊断及治疗具有重要指导作用，值得在临床推广。

       

      Abstract: Objective:To exp1ore the diagnostic and differentia1 va 1ue of pu1monary function test in e1der1y chronic obstructive pu1monary disease (COPD) and coronary heart disease (CHD).Methods:Subjects se1ected in our hospita1 in March 2015 March to2017 admitted 60 patients with coronary heart and 60 patients with COPD, respective1y, the same period se1ected 60 hea1thy peop1e of physica1 examination as contro 1 group. Using Masterscreen PFT pu 1monary function of a11 patients and contro 1 group were measured by conventiona 1 pu 1monary venti1ation and diffusion function and1ung vo1ume, the contents inc1ude pu1monary function, pu1monary conditions, and1ung vo1ume. Objective to ana1yze the diagnostic and differentia1 va 1ue of pu1monary function parameters in COPD and coronary heart disease.Resu1ts:COPD group and CHD group VC, PEF, FV, C, FEV1, FEVI/FVC, DLCO, DLCO/VAFRC index were significantly lower than the control group (P<0.01), COPD group was significantly lower than that of the coronary heart disease group(P<0.01); COPD group and CHD group FRC, TLC, RV and RV/TLC levels were significantly lower than the control group(P<0.01), COPD group was significantly lower than that of the coronary heart disease group(P<0.01); COPD group and CHD group FRC, RV and RV/ TLC was significantly higher than that of In the control group(P<0.01), the COPD group was significantly higher than the coronary heart disease group(P<0.01) .Conc1usion:The 1 ung function test can effective1y diagnose seni1e COPD and coronary heart disease, and can effective1y identify the e1der1y COPD and coronary heart disease to p1ay an important ro1e in ear1y diagnosis and treatment. It is worth in c1inica1 promotion.

       

      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回